Liven Pharma Limited (PSX: LIVEN) and Hoover Pharma (Private) Limited have entered preliminary, non-binding discussions regarding a potential acquisition of Hoover Pharma, the company disclosed at the main bourse today.
The talks are exploratory in nature, with both sides currently assessing the viability and feasibility of such a transaction. No final decision has been taken, and the discussions remain subject to further evaluation, regulatory approvals, and the completion of detailed due diligence.
The disclosure was made to ensure transparency and to keep the stock exchange and stakeholders informed. The companies clarified that the communication should not be interpreted as confirmation of any definitive agreement, arrangement, or commitment at this stage.
The principal activity of LIVEN is the manufacturing of pharmaceuticals and allied products.
Get the latest business news, market insights, and economic updates wherever you prefer.
Add ProPakistani to Preferred Sources and see more of our stories in Google Search and Top Stories.